WARSAW, Ind., May 04, 2018 -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that Ernst & Young (EY) has named President & CEO, Mark Throdahl, a finalist for the Entrepreneur of The Year® 2018 Award in the Midwest Region. The awards program recognizes entrepreneurs excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. OrthoPediatrics was selected as a finalist by a panel of independent judges. Award winners will be announced at a gala on June 13 at Navy Pier Grand Ballroom in Chicago.
“We are thrilled to receive this prestigious recognition,” said Mr. Throdahl. “It validates our belief that entrepreneurship is much more than having a new idea. It’s about continuously reassessing our strategy and implementing the operating, quality, and financial systems that drive performance. It’s about consistent growth that attracts blue chip investors. And, most importantly, it’s about building an entrepreneurial culture that engages everybody in the Company. Truly, every OrthoPediatrics associate deserves credit for this recognition.”
For more than 30 years, the Entrepreneur of the Year program has expanded to recognize business leaders in more than 145 cities and more than 60 countries throughout the world. Regional award winners are eligible for consideration for the Entrepreneur of The Year National competition. Award winners in several national categories, as well as the Entrepreneur of The Year National Overall Award winner, will be announced at the Entrepreneur of The Year National Awards gala in Palm Springs, California, on November 17, 2018. The awards are the culminating event of the Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 24 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 37 countries outside the United States.
Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
[email protected] / [email protected]


Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 



